Status:
RECRUITING
Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Standard of Care
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
Isala
Saxenburgh Group
Conditions:
Head and Neck Cancers
Laryngeal Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate whether Telemedicine follow-up is a satisfactory and safe alternative to traditional follow-up care for patients treated for early glottic (vocal cord) c...
Eligibility Criteria
Inclusion
- patients who underwent TOLS for early stage glottic squamous cell carcinoma (T1 or carcinoma-in-situ)
- a one-way travel time to the HNOC of ≥45 minutes (intervention group) or \< 30 minutes (control group)
- within 2 years postoperatively
- can speak and write Dutch
Exclusion
- Patients will be excluded if they continue to undergo follow-up for other (head and neck) cancers in the HNOC.
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT06940505
Start Date
April 1 2025
End Date
June 1 2027
Last Update
August 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Groningen
Groningen, Provincie Groningen, Netherlands, 9713GZ